Navigation Links
Halozyme Therapeutics to Host First Quarter 2011 Financial Results Conference Call on May 6
Date:4/29/2011

SAN DIEGO, April 29, 2011 /PRNewswire/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced it plans to report first quarter 2011 financial results on Friday, May 6, 2011 before the open of the financial markets. The announcement will be followed by a conference call with the investment community at 8:00 a.m. PDT (11:00 a.m. EDT), which will be simultaneously broadcast over the Internet. Management will discuss the financial results and highlights for the first quarter of 2011 and provide a product pipeline update.

(Logo: http://photos.prnewswire.com/prnh/20100302/LA63139LOGO)

To participate by telephone, please dial 877.407.8037 for domestic callers or 201.689.8037 for international callers. Those interested in listening to the conference call live via the Internet may do so by visiting the Investor Relations section of the company's Web site at www.halozyme.com. Shortly after the call an audio replay will be available on Halozyme's Web site for seven days. A telephone replay will be available by dialing 877.660.6853 from the U.S., or 201.612.7415 for international callers and using account # 367 and ID # 371588.  

About Halozyme

Halozyme Therapeutics is a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the insulin, cancer, dermatology and drug delivery markets. The company's product portfolio is based primarily on intellectual property covering the family of human enzymes known as hyaluronidases and additional enzymes that affect the extracellular matrix. Halozyme's Enhanze™ technology is a novel drug d
'/>"/>

SOURCE Halozyme Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Halozyme Therapeutics Reports Fourth Quarter and Year End 2010 Financial Results
2. Halozyme Therapeutics to Host Fourth Quarter and 2010 Financial Results Conference Call on March 11
3. Halozyme Therapeutics to Present at J.P. Morgan Healthcare Conference on January 12
4. Halozyme Therapeutics Realigns Management
5. Halozymes rHuPH20 With Recombinant Human Insulin Demonstrates Glycemic Control Comparable to Lispro
6. Halozyme Therapeutics Announces Implementation of Development Focused Strategy
7. Halozyme Therapeutics to Host Analyst Meeting on October 14 in New York
8. Halozyme Therapeutics Announces Public Offering of Common Stock
9. Halozyme Provides HYLENEX® Product Reintroduction Update
10. Halozyme Therapeutics Begins Phase 1 Clinical Trial of Bisphosphonate Administered With rHuPH20 Enzyme
11. Halozyme Therapeutics Announces Roche Begins Phase 1 Clinical Trial and Selects Fourth Exclusive Biologic Target
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... LONDON , July 11, 2014 /PRNewswire/ ... of visitors to Safety & Health Expo ... by the move to London ... senior management attending exhibition.     ... (Photo: http://photos.prnewswire.com/prnh/20140711/696892-a ) ...
(Date:7/10/2014)... , 11. Juli 2014 /PRNewswire/ ... Kameras für die molekulare Bildgebung, einschließlich ... heute die CE-Zulassung für sein Navigator ... kann Dilon das Produkt jetzt europaweit ... den Großteil der europäischen Länder ausgedehnt ...
(Date:7/10/2014)... , July 10, 2014 Integrated Silicon ... in advanced memory and analog IC solutions, today announced ... Thursday, July 24, 2014, at 7:00 a.m. Pacific Time ... results for the fiscal 2014 third quarter ended June ... via telephone, dial 1-888-556-4997 before 6:50 a.m. Pacific time ...
Breaking Medicine Technology:UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 2UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 3UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 4Dilon erhält CE-Zulassung für sein Navigator-Gamma-Sondensystem 2
(Date:7/11/2014)... (PRWEB) July 12, 2014 According ... the total market is expected to register a ... 2019. , Browse 71 market data tables and ... TOC on "C4ISR Market"., http://www.marketsandmarkets.com/Market-Reports/c4isr-market-1315.html , ... report., http://www.marketsandmarkets.com/requestCustomization.asp?id=1315 , The report provides ...
(Date:7/11/2014)... Butler Mobility has recently updated the paint ... . Previously the two standard colors were beige and ... tone colors as standard colors at no additional charge! ... but will enhance the beauty of the stairway. Homeowners ... scheme or individual décor. , The new selection of standard ...
(Date:7/11/2014)... Thompson HealthDay Reporter THURSDAY, ... with HIV who was thought to be cured by immediate ... detectable levels of the AIDS-causing virus in her bloodstream, disappointed ... 4 years old, had remained virus-free even though she stopped ... had hoped her remission would open the door to a ...
(Date:7/11/2014)... (PRWEB) July 11, 2014 As ... investigation, Bernstein Liebhard LLP has been closely monitoring ... Drug Administration’s (FDA) Obstetrics and Gynecology Devices ... to mitigate the cancer risks associated with the ... surgeries. According to a report published by Dow ...
(Date:7/11/2014)... (PRWEB) July 11, 2014 Datalogic brings ... in improving sanitation hospital wide. With their new ... spread of disease, like the devastating MRSA, which claimed ... Gryphon GD4400-HC 2D and the Gryphon GM4400-HC ... barcodes and can even read barcodes off of troublesome ...
Breaking Medicine News(10 mins):Health News:C4ISR Market Estimated to Reach $93.04 Billion by 2019 - New Report by MarketsandMarkets 2Health News:C4ISR Market Estimated to Reach $93.04 Billion by 2019 - New Report by MarketsandMarkets 3Health News:C4ISR Market Estimated to Reach $93.04 Billion by 2019 - New Report by MarketsandMarkets 4Health News:Butler Mobility Products Announces Five New Standard Colors for Their Inclined Platform Lifts 2Health News:Mississippi Girl Thought Cured of HIV Shows Signs of Infection 2Health News:Mississippi Girl Thought Cured of HIV Shows Signs of Infection 3Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Financial Ties Between FDA Advisory Panel Members and Manufacturers of Power Morcellators 2Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Financial Ties Between FDA Advisory Panel Members and Manufacturers of Power Morcellators 3Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Financial Ties Between FDA Advisory Panel Members and Manufacturers of Power Morcellators 4Health News:Stop Spreading Disease with the New Disinfectant-Ready Bar Code Scanner 2Health News:Stop Spreading Disease with the New Disinfectant-Ready Bar Code Scanner 3
... cause of adult-onset blindness, experts note , TUESDAY, Sept. 25 ... vision checked if they have access to health care, as ... say. , However, minorities with diabetes or people living in ... when they know why it is important to do so. ...
... resonance imaging (fMRI) have found a new marker which ... to a study published in the October issue of ... potential functional, rather than structural, brain markerseparate from atrophythat ... patients, said the studys lead author, Jeffrey R. Petrella, ...
... BOTHELL, Wash., Sept. 25 Cardiac Science,Corporation ... in advanced cardiac monitoring,and defibrillation products, today ... other lay rescuers from the Pittsburgh school ... defibrillator,(AED). (Logo: http://www.newscom.com/cgi-bin/prnh/20050913/SFTU139LOGO ) ...
... for research to improve health and welfare of ... companion animals and wildlife, ... for individuals or groups to demonstrate love,for and help animals via ... about 120 animal health studies available,for sponsorship. Animal lovers are invited ...
... ... Program Oct. 1, MINNEAPOLIS and ST. PAUL, Minn., ... major health plans and,ClearWay Minnesota(SM) -- is launching a new program that ... who,want to stop smoking. The Minnesota Clinic Fax Referral Program begins,October 1, ...
... One of the ,100 Best Companies ... Consecutive Year, ABBOTT PARK, Ill., Sept. 25 After ... to change. Lucky for,her, it didn,t have to be her ... She has since had a second child and,continues to work ...
Cached Medicine News:Health News:Regular Eye Screens Spot Diabetic Vision Trouble 2Health News:Radiologists identify early brain marker of Alzheimer's disease 2Health News:Radiologists identify early brain marker of Alzheimer's disease 3Health News:Cardiac Science Applauds Mass AED Training of Pittsburgh Educators 2Health News:Cardiac Science Applauds Mass AED Training of Pittsburgh Educators 3Health News:Cardiac Science Applauds Mass AED Training of Pittsburgh Educators 4Health News:Morris Animal Foundation 2008 Sponsorship Guide Available, Details Current Animal Health Studies 2Health News:Morris Animal Foundation 2008 Sponsorship Guide Available, Details Current Animal Health Studies 3Health News:Health Organizations Join Forces Around Quit-Smoking Help 2Health News:Abbott Again Honored as Top Company for Working Moms 2Health News:Abbott Again Honored as Top Company for Working Moms 3
The Oscor PACE 101 H is an external single chamber cardiac demand pacemaker. The PACE 101 H feature an option for a atrial overdrive stimulation....
... pacing wire design offers reliable ... in the atrium and ventricle ... in one lead design. The ... ventricle are color-coded for easy ...
... proprietary quadripolar pacing wire design ... and sensing in the atrium ... bipolar wires in one lead ... atrium and ventricle are color-coded ...
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
Medicine Products: